MAPK8 and Alzheimer disease: Moreover, the effect was better in the EA-GV20+ST36 group, indicating that EA-GV20+ST36 could improve learning and memory impairment in AD rats by down-regulating 5-HT6R levels and inhibiting JNK signaling.